Evaluation of Celligent Biomimetic Water Gradient Contact Lens Effects on Ocular Surface and Subjective Symptoms.

Raúl Capote-Puente, José-María Sánchez-González, María Carmen Sánchez-González, María-José Bautista-Llamas
Author Information
  1. Raúl Capote-Puente: Optica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.
  2. José-María Sánchez-González: Optica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain. ORCID
  3. María Carmen Sánchez-González: Optica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain. ORCID
  4. María-José Bautista-Llamas: Optica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain. ORCID

Abstract

This study aimed to evaluate the non-invasive and subjective symptoms associated with Lehfilcon A water gradient silicone hydrogel contact lenses with bacterial and lipid resistance technology. A prospective, longitudinal, single-centre, self-controlled study was conducted among silicone hydrogel contact lens wearers. Non-invasive analysis of the pre-lens tear film was performed using the Integrated Clinical Platform (ICP) Ocular Surface Analyzer (OSA), and the meibomian glands were evaluated with the Cobra HD infrared meibographer. After 30 days of contact lens wear, the subjects were re-evaluated to determine the changes in conjunctival redness, subjective dry eye disease, tear meniscus height, lipid pattern, and non-invasive break-up time. Results showed that the lipid layer thickness decreased significantly from 2.05 ± 1.53 to 0.92 ± 1.09 Guillon patterns, and the tear meniscus height decreased from 0.21 ± 0.04 to 0.14 ± 0.03. The mean pre-lens non-invasive break-up time (NIBUT) significantly increased from 15.19 ± 9.54 to 25.31 ± 15.81 s. The standard Patient Evaluation of Eye Disease (SPEED) score also decreased from 7.39 ± 4.39 to 5.53 ± 4.83. The results suggest that Lehfilcon A significantly reduced lipid and aqueous tear film volume but improved break-up time and subjective dry eye symptoms.

Keywords

References

  1. Cont Lens Anterior Eye. 2021 Dec;44(6):101388 [PMID: 33293225]
  2. Eye Contact Lens. 2011 Mar;37(2):90-5 [PMID: 21301348]
  3. Optom Vis Sci. 2017 Apr;94(4):534-542 [PMID: 28338565]
  4. Clin Ophthalmol. 2022 Aug 30;16:2873-2884 [PMID: 36065354]
  5. Cont Lens Anterior Eye. 2018 Apr;41(2):193-200 [PMID: 29233456]
  6. Clin Optom (Auckl). 2020 Nov 20;12:203-211 [PMID: 33244285]
  7. Eye Contact Lens. 2017 Mar;43(2):95-99 [PMID: 27078615]
  8. Front Med (Lausanne). 2022 Aug 10;9:938484 [PMID: 36035382]
  9. Cont Lens Anterior Eye. 2019 Oct;42(5):475-481 [PMID: 30587408]
  10. Optom Vis Sci. 2006 Oct;83(10):758-68 [PMID: 17041322]
  11. Microvasc Res. 2014 Mar;92:62-71 [PMID: 24444784]
  12. Eye Vis (Lond). 2019 May 21;6:15 [PMID: 31139665]
  13. Clin Optom (Auckl). 2020 Feb 28;12:17-26 [PMID: 32184693]
  14. Clin Exp Optom. 2022 Apr;105(3):268-274 [PMID: 33735595]
  15. Exp Eye Res. 2020 Dec;201:108295 [PMID: 33038387]
  16. Clin Exp Optom. 2019 Sep;102(5):446-454 [PMID: 30630216]
  17. Optom Vis Sci. 2012 May;89(5):E760-9 [PMID: 22488268]
  18. Eye Contact Lens. 2006 Dec;32(6):281-6 [PMID: 17099389]
  19. Cont Lens Anterior Eye. 2017 Oct;40(5):273-282 [PMID: 28602547]
  20. Eye Contact Lens. 2008 Nov;34(6):326-30 [PMID: 18997542]
  21. Br J Ophthalmol. 2014 Sep;98(9):1168-76 [PMID: 24627252]
  22. Materials (Basel). 2019 Jan 14;12(2): [PMID: 30646633]
  23. Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3307-3313 [PMID: 30025086]
  24. Clin Optom (Auckl). 2017 Feb 15;9:41-48 [PMID: 30214359]
  25. Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5752-5761 [PMID: 30516819]
  26. Transl Vis Sci Technol. 2021 Sep 1;10(11):5 [PMID: 34473222]
  27. J Biomater Appl. 2021 Mar;35(8):933-946 [PMID: 33135571]
  28. ACS Omega. 2021 Feb 26;6(10):7058-7067 [PMID: 33748619]
  29. Optom Vis Sci. 2016 Aug;93(8):881-91 [PMID: 27092926]
  30. Invest Ophthalmol Vis Sci. 2013 Oct 18;54(11):TFOS7-TFOS13 [PMID: 24058135]
  31. Eye Contact Lens. 2022 Sep 1;48(9):356-361 [PMID: 36002943]
  32. Clin Exp Optom. 2018 Jan;101(1):13-17 [PMID: 28503827]
  33. Exp Eye Res. 2013 Dec;117:88-98 [PMID: 23886658]
  34. J Fr Ophtalmol. 2020 Apr;43(4):e123-e131 [PMID: 31928786]
  35. Cont Lens Anterior Eye. 2013 Jan 15;36 Suppl 1:S9-13 [PMID: 23347575]
  36. Cont Lens Anterior Eye. 2019 Jun;42(3):246-252 [PMID: 30819629]
  37. Cont Lens Anterior Eye. 2018 Feb;41(1):117-121 [PMID: 28927731]
  38. J Ophthalmol. 2017;2017:5131764 [PMID: 28280635]
  39. Eye Contact Lens. 2013 Jan;39(1):13-9 [PMID: 23271477]
  40. Cont Lens Anterior Eye. 2016 Oct;39(5):342-52 [PMID: 27131891]
  41. Transl Vis Sci Technol. 2019 Dec 12;8(6):31 [PMID: 31853426]
  42. Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5616-5624 [PMID: 27768798]
  43. Cornea. 2016 Nov;35 Suppl 1:S65-S70 [PMID: 27617877]
  44. Sci Rep. 2021 Jun 14;11(1):12460 [PMID: 34127727]
  45. Cont Lens Anterior Eye. 2019 Jun;42(3):273-277 [PMID: 30497902]
  46. Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):655-676 [PMID: 34487223]
  47. Optom Vis Sci. 2012 Oct;89(10):1435-42 [PMID: 22960615]
  48. Biointerphases. 2020 Aug 31;15(4):041013 [PMID: 32867505]
  49. Clin Exp Optom. 2018 Mar;101(2):188-192 [PMID: 29023989]
  50. Int J Mol Sci. 2019 Mar 15;20(6): [PMID: 30875896]
  51. Ocul Surf. 2017 Jul;15(3):438-510 [PMID: 28736340]
  52. Exp Eye Res. 2020 Dec;201:108294 [PMID: 33039458]

Word Cloud

Created with Highcharts 10.0.0±lipidtear0non-invasivecontactbreak-uptimesubjectivelenspre-lensfilmdecreasedsignificantlystudysymptomsLehfilconsiliconehydrogelOcularSurfacedryeyemeniscusheightpattern15315Evaluation394aimedevaluateassociatedwatergradientlensesbacterialresistancetechnologyprospectivelongitudinalsingle-centreself-controlledconductedamongwearersNon-invasiveanalysisperformedusingIntegratedClinicalPlatformICPAnalyzerOSAmeibomianglandsevaluatedCobraHDinfraredmeibographer30dayswearsubjectsre-evaluateddeterminechangesconjunctivalrednessdiseaseResultsshowedlayerthickness2059209Guillonpatterns21041403meanNIBUTincreased19954253181sstandardPatientEyeDiseaseSPEEDscorealso7583resultssuggestreducedaqueousvolumeimprovedCelligentBiomimeticWaterGradientContactLensEffectsSubjectiveSymptoms

Similar Articles

Cited By